Page last updated: 2024-09-03

reboxetine and Bone Loss, Osteoclastic

reboxetine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elefteriou, F; Hahn, MK; Krueger, JJ; Ma, Y; Nyman, JS; Redmon, SN; Uppuganti, S	1

Other Studies

1 other study(ies) available for reboxetine and Bone Loss, Osteoclastic

Article	Year
Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. The Journal of biological chemistry, 2013, Oct-18, Volume: 288, Issue:42 Topics: Animals; Antidepressive Agents; Biological Transport, Active; Bone Remodeling; Bone Resorption; Humans; Mice; Mice, Mutant Strains; Morpholines; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Osteoclasts; Psychomotor Disorders; Reboxetine; Sympathetic Nervous System	2013

Article

Year

Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.

The Journal of biological chemistry, 2013, Oct-18, Volume: 288, Issue:42

Topics: Animals; Antidepressive Agents; Biological Transport, Active; Bone Remodeling; Bone Resorption; Humans; Mice; Mice, Mutant Strains; Morpholines; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Osteoclasts; Psychomotor Disorders; Reboxetine; Sympathetic Nervous System

2013